Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
(World News USA)

NEW YORK, Dec. 5, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, will discuss the company`s strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance during its annual investor conference today in New York City. Highlights of today`s conference include:Reaffirming October 2019 financial guidance1Projected 2020 global sales of $4.5-5.0 billion; underlying2 growth 10-12%Estimated 2020 adjusted earnings per share3 $6.05-6.30Projected 2020 TAVR sales of $2.9-3.2 billion; underlying growth 12-15%Global transcatheter...